TIDMABC

RNS Number : 6154R

ABCAM Plc

22 September 2017

 
 For immediate release   22 September 2017 
 

ABCAM PLC

("Abcam")

Posting of Annual Report and Accounts

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, announces that its Annual Report and Accounts for the year ended 30 June 2017 has been posted to shareholders and is available at the Company's investor relations website, www.abcamplc.com.

For further information, please contact:

 
Abcam plc 
Suzanne Smith, Company Secretary        + 44 (0) 1223 
 Julia Wilson, Investor Relations        696 000 
 
J.P.Morgan Cazenove - Nominated         + 44 (0) 20 
 Adviser & Corporate Broker              7742 4000 
James Mitford / Candelle Chong 
 
 FTI Consulting 
 Ben Atwell / Brett Pollard / Natalie     +44 (0) 20 
 Garland-Collins                          3727 1000 
 
 

Notes to Editors

About Abcam plc

As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated biological binders and assays to address important targets in critical biological pathways.

Already a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use Abcam's affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences.

By actively listening to and collaborating with researchers, the Company continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results.

Abcam's twelve locations are in the world's leading life science research hubs, enabling local services and multi-language support. Founded in 1998 and headquartered in Cambridge, UK, the Company sells to more than 100 countries. Abcam was admitted to AIM in 2005 (AIM: ABC).

To find out more, please visit www.abcam.com and www.abcamplc.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSOKBDNQBKDKCB

(END) Dow Jones Newswires

September 22, 2017 10:32 ET (14:32 GMT)

Abcam (LSE:ABC)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Abcam Charts.
Abcam (LSE:ABC)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Abcam Charts.